Sign in

CIK 0001752828

  • Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831702591
Phone
+1 908-768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Haines John R acquired 65,617 shares (grant or award)
  5. 4 Grant or award Chief Executive Officer acquired 131,234 shares (grant or award)
  6. 4 Grant or award Dunn Keary acquired 16,405 shares (grant or award)
  7. 4 Grant or award Pres, Functional Regeneration acquired 32,809 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 41,011 shares (grant or award)
  9. 4 Grant or award Chief Technology Officer acquired 19,686 shares (grant or award)
  10. 4 Grant or award Chief Business Officer acquired 16,405 shares (grant or award)
  11. 4 Option exercise 10% owner acquired 6,640,694 shares (option exercise)
  12. 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 10 · 191 filings